Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06722807 · ClinicalTrials.gov registry record · NA
ClAmpless, Sutureless PartIAl Nephrectomy for Renal Masses
A NA study of Renal Cell Carcinoma (RCC), sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT06722807 is a NA study of Renal Cell Carcinoma (RCC) that is actively recruiting participants, run by University of Florida. The registered enrollment target is 59 participants, below the 436-participant average among 11 other Renal Cell Carcinoma (RCC) trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06722807, a NA study of Renal Cell Carcinoma (RCC), is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
During partial nephrectomy surgery, efforts at minimizing ischemia while maximizing renal parenchymal volume are desirable to preserve renal function1,2. Not only clamping of the hilum but the renorrhaphy portion of the procedure also can have a significant negative impact on renal function3-5. It is possible to perform this procedure without clamping the hilum and also without formal renorrhaphy. However robust prospective formal evaluation of safety, risks, and potential benefits and whether or not the technique can be employed in a generalized fashion has not been studied. Demonstration of safety and generalizability may open a whole new avenue of approaching nephron sparing and renal function sparing kidney surgery and decrease potential risks for long term kidney disease in patients with renal masses. This study will investigate the safety, efficacy, and generalizability of the use of clampless, sutureless partial nephrectomy in the treatment of renal cell carcinoma.
Conditions Studied
Interventions
- PROCEDURE sutureless, clampless partial nephrectomy
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2025-06-10 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06722807
The ClinicalTrials.gov registry entry for NCT06722807 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 436-participant average among 11 other Renal Cell Carcinoma (RCC) trials with a reported enrollment target (86% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Renal Cell Carcinoma (RCC) appearing as the primary indexed condition, and to 1 intervention - of which sutureless, clampless partial nephrectomy is the first listed.
NCT06722807 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06722807 about?
NCT06722807 is a clinical study titled "ClAmpless, Sutureless PartIAl Nephrectomy for Renal Masses". During partial nephrectomy surgery, efforts at minimizing ischemia while maximizing renal parenchymal volume are desirable to preserve renal function1,2. Not only clamping of the hilum but the renorrhaphy portion of the procedure also can have a significant negative impact on renal function3-5. It i...
What is the current status of trial NCT06722807?
This trial is currently recruiting. It is a NA study. The enrollment target is 59 participants. The study started on 2025-06-10. Estimated completion is 2027-01.
What conditions does trial NCT06722807 study?
This clinical trial studies the following conditions: Renal Cell Carcinoma (RCC).
What interventions are being tested in trial NCT06722807?
The interventions under investigation include: sutureless, clampless partial nephrectomy (PROCEDURE).
Who is sponsoring clinical trial NCT06722807?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06722807 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Cell Carcinoma (RCC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
RECRUITING · NA
-
Investigation of Lymph Node Biology in Kidney Cancer
RECRUITING · NA
-
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
RECRUITING · Phase 1
-
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
RECRUITING · Phase 1
-
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RECRUITING · Phase 3
-
A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.